China · Advertising framework
Influencer marketing for healthcare providers in China
General market orientation, not campaign clearance. Research scope and dates
Product and service rules
Medical institution advertising follows a narrow reviewed route
Legal requirement — paraphrased
The medical advertising measures require review and restrict ordinary institutional advertising to specified establishment information. They prohibit cure guarantees, treatment-effect rates and testimonial endorsements. Only legally established medical institutions may publish medical-service advertising through this route.
Sources: Measures for the Administration of Medical Advertising; Guidelines for Medical Advertising Supervision, 2025
Read the 2025 enforcement guidance alongside the underlying rules
Regulator guidance
The 2025 SAMR guidelines describe discretion for specified truthful institutional-information cases and minor changes. These are not a general exemption from medical advertising law or permission to promote treatments freely. Aesthetic ads creating appearance anxiety or targeting minors for non-therapeutic procedures raise specific enforcement concerns.
Sources: Guidelines for Medical Advertising Supervision, 2025
Apply the 2025 identification guidance to factual listings and health education
Regulator guidance
Applies when: Mainland Chinese medical institutions or their staff publish information about medical services.
The 2025 identification guidelines distinguish specified factual institutional information from advertising. Tabulated information on a third-party platform can fall outside advertising where it meets the guideline conditions and contains no subjective promotion.
Comparative claims, guarantees, promotional case stories and links from health education to the corresponding medical service can cross the boundary into advertising. A clinician’s name and professional affiliation in genuine educational material are not by themselves equivalent to a promotional endorsement.
Sources: SAMR / NHC / NATCM — Medical Advertising Identification Guidelines, 2025 · Medical Advertising Identification Guidelines sections 5–8
Beijing: distinguish the TCM review authority
Regulator guidance
Applies when: A Beijing medical institution is advertising, including licensed TCM services.
Beijing TCM, integrated Chinese/Western and ethnic-medicine institutions apply through the TCM administration; general and dental hospitals use the health commission. The TCM authority requires the finished sample through the electronic medical-institution system, matching licensed institutional details and the review number. The certificate is valid for one year; changed creative or changed practice information requires a new application. This is a Beijing procedure, not a filing map for all provinces.
Channel rules
Check the complete consumer-facing message
Regulator guidance
Advertising must be truthful and clear. Review the accuracy of stated functions, benefits, provider details, prices and promises under the Advertising Law. Sector review requirements and prohibited claims continue to apply even when the advertiser identifies the commercial nature of a message.
Do not disguise regulated advertising as health education
Legal requirement — paraphrased
Reviewed health advertisements must remain within the approved content. Internet rules prohibit disguised medical, medicine, device and health-food advertisements presented as health knowledge; related supplier contacts or shopping links alongside that knowledge are specifically restricted. Paid search needs clear advertising identification.
Health information and automated marketing need separate review
Legal requirement — paraphrased
PIPL treats medical and health information as sensitive personal information, with heightened necessity and protection requirements. Assess applicable separate-consent obligations and the limited non-consent bases. Automated commercial marketing must provide the required non-personalised option or convenient refusal route; check cross-border data flows separately.
Sources: Personal Information Protection Law
Do not apply the ordinary-data threshold to health data
Regulator guidance
The CAC identifies medical and health information as sensitive personal information. Its under-100,000-person ordinary-data exemption excludes sensitive data. Subject to stated exemptions, a non-critical-infrastructure operator exporting sensitive information for fewer than 10,000 people must use the standard-contract or certification route; at least 10,000 requires a security assessment. Important data and critical-infrastructure operators have separate assessment triggers. Count people from 1 January and document the specific exemption, if any; an advertising consent checkbox does not establish a transfer mechanism.
Sources: Cross-border data provisions — official explanatory FAQ
Brief the creator on the permitted message
Editorial recommendation
Check whether endorsements are permitted for the selected offer before contracting a creator. Record payments, gifts and affiliate links; specify the required advertising identification, approved claims, editing controls and takedown process.
Exclude restricted health and beauty ads from media directed at minors
Legal requirement — paraphrased
Applies when: The internet medium is directed at minors and the advertisement falls within an Article 12 sector.
Article 12 prohibits medical, medicine, medical-device, health-food, special-medical-purpose food, cosmetic and beauty advertising on internet media directed at minors. The restriction concerns the medium’s audience and context, not only a chosen targeting checkbox.
First classify the advertised offer within the listed sectors; ordinary wellness content is not automatically a regulated product advertisement.
Campaign workflow
Healthcare Providers & Professionals: prepare the review
Editorial recommendation
Verify the provider entity, professional registration and claimed specialties. Check the professional regulator for the practitioner type and region. Review patient stories, comparisons, titles and recruitment language before publication.
Keep a traceable campaign decision
Editorial recommendation
Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.
Pre-publication checklist
- Verify the provider entity, professional registration and claimed specialties.
- Check the professional regulator for the practitioner type and region.
- Review patient stories, comparisons, titles and recruitment language before publication.
- Record product or provider eligibility before approving claims.
- Archive the final creative and its evidence, permissions and review decisions.
- Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.
Scope and unresolved questions
- Mainland only. Beijing TCM review, national online-retail display conditions, warning presentation and a cross-border data route are documented. Other provincial filing procedures, actual seller permissions, platform account rules, product-specific Chinese assets and the transfer facts still require review.
- This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates
Provider communication through influencer collaborations in China needs an accurate account of qualifications, professional scope and the available care. Check the regulator for the actual practitioner and location before using comparisons, patient stories or specialty titles.
Creator selection and commercial disclosure are only part of an influencer review. Examine the person's role, the spoken and visual claims, supplied benefits and the final publication together; a personal experience can still communicate a regulated claim.
General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.
How to use this national baseline
Editorial overview
This framework combines researched national rules with editorial review steps. Mainland China only; Hong Kong, Macau and Taiwan are outside this pack. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.
The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.
Sources
- Measures for the Administration of Medical Advertising
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- Guidelines for Medical Advertising Supervision, 2025
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- Advertising Law of the People’s Republic of China
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- Internet Advertising Measures, SAMR Order 72
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- Personal Information Protection Law
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- SAMR / NHC / NATCM — Medical Advertising Identification Guidelines, 2025
Targeted review on 25 October 2026. This date does not certify the currency of other sources or resolve local and campaign-specific requirements.
- Beijing TCM medical-advertising review FAQ
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
- Cross-border data provisions — official explanatory FAQ
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
- Internet Advertising Measures — official HTML text
Targeted review on 25 October 2026. This date does not certify the currency of other sources or resolve local and campaign-specific requirements.
From framework to action
Local expertise in China
Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in China.
Medical & health marketing
No partners listed in this category yet.
Marketing & sales advisory
No partners listed in this category yet.
Business & project coordination
No partners listed in this category yet.
Join the local partner directory
Would you like your company to be listed?
Talk to us about the terms of a listing. Leave your details and we will get in touch.